Home Home Home Inbox Home Search

Event

Concordance Between Health Care Utilization and Symptom-Defined Exacerbations in Patients with COPD: Results from the Acute Exacerbation and Respiratory InfectionS (AERIS) Study [Board No. 624]

Location: Board no. 624
Session Type: RAPiD: Rapid Abstract Poster Discussion Session
Monday
May
21
9:15 AM
11:15 AM

Speaker(s)/Author(s)

Ruby Sung

MS
GSK

Kristoffer Ostridge

MBBS, BSc(Hons)
Southampton NIHR Respiratory Biomedical Research Unit & University of Southampton Faculty of Medicin;University of Southampton

Ruth Tal-Singer

PhD
GlaxoSmithKline;GSK;GSK R&D

Jeanne-Marie Devaster

MD
GSK;GSK Vaccines

Nancy K. Leidy

PhD
Evidera

Tom M. Wilkinson

MBBS PhD
Southampton NIHR Respiratory Biomedical Research Unit & University of Southampton Faculty of Medicin;University of Southampton

Nicholas Locantore

PhD
GlaxoSmithKline;GSK

Susan D. Collier

BSc, MBchB
GlaxoSmithKline;GSK

Bruce Miller

PhD
GlaxoSmithKline;GSK

Karl J. Staples

BSc(Hons), PhD
University of Southampton;University of Southampton Faculty of Medicine, Southampton General Hospital

View Abstract

Concordance Between Health Care Utilization and Symptom-Defined Exacerbations in Patients with COPD: Results from the Acute Exacerbation and Respiratory InfectionS (AERIS) Study

Parent Sessions

  • B21 - EXACERBATIONS AND READMISSION ISSUES IN COPD...
    05-21-2018 9:15 AM - 11:15 AM
    • Home Home Home Inbox Home Search